Enter patient information:
Factors affecting non-cancer lethality
Non-cancer lethality is based on data from the latest U.S. Census Bureau National Vital Statistics Reports. Enter the patient's age.
Age:
Factors affecting cancer lethality
Cancer lethality is based upon the combination of a number of contributing factors. You may specifiy these information below.
Tumor Diameter: (cm)
# of Positive Nodes:
Nodal detail input here (optional)
ER Status:
PR Status:
HER2 Status:
Histological Type:
Grade:
Select all applicable identified nodal information
(optional, used for staging purposes only)		 X
Clinically apparent metastasis in:
   movable ipsilateral axillary lymph node(s)
   fixed or matted ipsilateral axillary lymph node(s)
   ipsilateral internal mammary nodes
Any metastasis in:
   ipsilateral infraclavicular lymph node(s)
   ipsilateral supraclavicular lymph node(s)
Pathology analysis:
   No metastasis histologically, no further examination
   No metastasis histologically; IHC and/or H&E staining negative
   Isolated Tumor Cells found (<0.2mm)
   Micrometastasis (>0.2mm and <2.0mm) in axillary nodes
   Metastasis in axillary lymph nodes (>2.0mm)
   Micrometastasis (>0.2mm and <2.0mm) in internal mammary nodes
   Metastasis in internal mammary lymph nodes (>2.0mm)
   Molecular findings (RT-PCR):
       unknown negative positive
Other information:
   Extension of tumor to chest wall (not including pectoralis muscle)
   Edema (including peau d’orange) or ulceration of the skin of the breast, or satellite skin nodules confined to the same breast
   Evidence of distant metastasis
finished
Therapy options
A proportional risk reduction model is used in determining the effects of adjuvant therapy. NOTE: we have adopted the same reduction in death values that were adopted by AdjuvantOnline.
Hormonal therapy:
Chemo-
therapy:
Questions or trouble? Click here for the calculator FAQ

Display as:
Classification:   TxNxMx       AJCC Stage: unknown
Cancer Mortality: _% expected 15-year Cancer Death Rate.
_% 15-year Kaplan-Meier cancer death rate
Life Expectancy:
 Without therapy, this cancer shortens the life expectancy of a __-year-old woman by _ years. (from __ years to __ years
Therapy benefit:
 The therapy selected would improve average life expectancy by 0 years, or
0 days over expectancy without therapy.
__% fewer cancer deaths after 15 years